A case of human T-cell lymphotrophic virus type I (HTLV-1)-associated myelopathy (HAM) occurring in a 60-year-old Peruvian female with a history of hemodialysis due to chronic renal failure (CRF) is reported. The patient was a lifelong resident of Lima, Peru, an endemic area for HTLV-1 infections1,2,3. The clinical course was characterized by abrupt onset and rapid progression of neurological signs and symptoms: paraparesia end neurogenic bladder. There are reports in Latin America with similar prevalence with B and C hepatitis on hemodialysis group4,5,6. There are no reports in Peru, also no screening in kidney transplantation (receptor and donors). Key words: Myelopathy; HTLV-1; Chronic renal failure. (source: MeSH NLM)   DOI: 10.25176/RFMH.v18.n2.1292  

Reporte de un caso de mielopatía asociada (HAM) a virus humano linfotrofico de células T tipo 1 (HTLV1) que ocurre en paciente mujer de 60 años con enfermedad renal crónica en hemodiálisis, además, con antecedente de diabetes mellitus 2. Paciente residente de Lima, Perú, zona endémica de HTLV-11,2,3. El cuadro clínico se caracterizó por síntomas y signos neurológicos de inicio abrupto y evolución rápida: paraparesia con imposibilidad de caminar y vejiga neurogenica con sonda vesical permanente. En la región, se reporta prevalencia de HTLV-1 en pacientes en hemodiálisis similar a la de hepatitis B y C4,5,6. No existen cifras de esta infección en el Perú. Además, no se realiza despistaje en donantes y/o receptores de trasplante renal. Palabras clave: Mielopatía; HTLV-1; Insuficiencia renal crónica. (fuente: DeCS BIREME)   DOI: 10.25176/RFMH.v18.n2.1292

Objectives: To compare mortality in patients with COVID-19 and renal failure and need for hemodialysis from a general hospital in Lima, Peru and data from the world literature, and according to geographic areas in the world. Methods: Secondary research: evaluative review. PubMed was the database used for the bibliographic search. The keywords “renal failure”, “COVID 19” and “mortality” were used and the filters meta-analysis and systematic reviews. Thirteen articles were included. Results: The frequency of acute renal failure (AKI) and COVID-19 ranged between 8.4 and 26% and in Lima, Peru it was 22.6%; the hemodialysis (HD) rates in patients with COVID-19 was 2.97%, continuous renal replacement therapy (CRRT) was reported in AKI: Asia 1.4%, Europe 5.7% and North America 4.0% and in Lima, Peru 44.1% had CKD V on HD and 12.9% received HD for the first time (ARF 9.7% and CKD 3.2...